SCHEMBL7316211

SCHEMBL7316211

O=C(Nc1ccc(F)cc1F)c1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ORAI1 Q96D31 3/20 0.63
TRPC3 Q13507 2/20 0.53
TRPC1 P48995 1/20 0.53
STIM1 Q13586 1/20 0.53
CRACR2A Q9BSW2 1/20 0.50
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
GAA P10253 1/20 0.49
TP53 P04637 2/20 0.48
MAPT P10636 1/20 0.48
TRPC5 Q9UL62 1/20 0.48
KMT2A Q03164 2/20 0.47
THRB P10828 1/20 0.47
LMNA P02545 1/20 0.47
F10 P00742 2/20 0.46
MLLT1 Q03111 1/20 0.46
POLB P06746 1/20 0.45
HDAC1 Q13547 1/20 0.45
F2 P00734 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7321708 0.87 ORAI1 (0.57) ORAI1TRPC3TRPC1STIM1GAA
SCHEMBL7327988 0.85 ORAI1 (0.81) ORAI1TRPC3TRPC1STIM1CRACR2A
SCHEMBL7317754 0.85 ORAI1 (0.81) ORAI1TRPC3TRPC1STIM1CRACR2A
SCHEMBL7328531 0.82 CRACR2A (0.72) ORAI1TRPC3TRPC1STIM1CRACR2A
SCHEMBL7317372 0.81 ORAI1 (0.55) ORAI1TRPC3TRPC1STIM1CRACR2A
SCHEMBL7317734 0.80 ORAI1 (0.74) ORAI1TRPC3TRPC1STIM1CRACR2A
SCHEMBL7318849 0.80 ORAI1 (0.69) ORAI1TRPC3TRPC1STIM1CRACR2A
SCHEMBL7324206 0.80 ORAI1 (0.63) ORAI1TRPC3TRPC1STIM1CRACR2A
SCHEMBL14409389 0.80 ORAI1 (0.72) ORAI1TRPC3TRPC1STIM1CRACR2A
SCHEMBL7316339 0.80 ORAI1 (0.79) ORAI1TRPC3TRPC1STIM1CRACR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US claimed
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP disclosed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 ORAI1 3522/4885TRPC3 4362/4885TRPC1 4287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.